 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 January 1997 | Volume 126 Issue 2 | Pages 123-132
Background: The resurgence of tuberculosis in the United States is largely linked to the human immunodeficiency virus (HIV) epidemic. Despite this link, the epidemiology of tuberculosis and preventive strategies in patients infected with HIV are not completely understood.
Objectives: To determine the incidence and predictors of tuberculosis in HIV-infected persons.
Design: Prospective, multicenter cohort study.
Setting: Community-based cohort of persons with and without HIV infection at centers in the eastern, midwestern, and western United States.
Participants: 1130 HIV-seropositive patients without AIDS who were followed for a median of 53 months (814 homosexual men, 261 injection drug users, and 55 women who had acquired HIV through heterosexual contact).
Measurements: Delayed hypersensitivity response to purified protein derivative (PPD) tuberculin and mumps antigen, CD4 T-lymphocyte counts, and frequency of tuberculosis.
Results: 31 HIV-seropositive patients developed tuberculosis (0.7 cases per 100 person-years [95% CI, 0.5 to 1.0]). The most important demographic risk factor was location (adjusted risk ratio for eastern compared with midwestern and western United States, 4.1 [CI, 2.0 to 8.4]). Tuberculosis occurred more frequently in persons with CD4 counts of less than 200 cells/mm3 (1.2 cases per 100 person-years [CI, 0.7 to 1.9]) than in those with higher counts (0.5 cases per 100 person-years [CI, 0.3 to 0.8]). The rate of tuberculosis was highest among tuberculin converters (5.4 cases per 100 person-years [CI, 1.1 to 15.7]), lower among patients who were PPD positive at first testing (4.5 cases per 100 person-years [CI, 1.6 to 9.7]), and lowest among patients who remained PPD negative (0.4 cases per 100 person-years [CI, 0.2 to 0.7]). Tuberculosis was not reported among persons who had PPD reactions of 1 to 4 mm. Compared with that of patients who tested positive for mumps, the risk for tuberculosis of those who tested negative was increased about sevenfold if they were PPD positive (P < 0.03) and fourfold if they were PPD negative (P < 0.02).
Conclusions: Incidence of tuberculosis was higher in the eastern United States, in patients with CD4 counts of less than 200 cells/mm3, and in PPD-positive patients. Analysis of tuberculin reaction size supports the current interpretive criteria of the Centers for Disease Control and Prevention. Nonreactivity to mumps antigen indicated increased risk for tuberculosis independent of PPD response.
Author and Article Information
The Pulmonary Complications of HIV Infection Study Group
ARTICLE
Incidence of Tuberculosis in the United States among HIV-Infected Persons
Grant Support: In part by contract NO1-HR-76033 and grant RO1 HL48511-02 from the National Heart, Lung, and Blood Institute. Cosponsored by the National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Requests for Reprints: Norman Markowitz, MD, Division of Infectious Diseases, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202.
Current Author Addresses: Drs. Markowitz and Kvale: Division of Infectious Diseases, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202.
This article has been cited by other articles:
|
|
 |
|
  S. M. Marks, C. Murrill, T. Sanchez, K.-l. Liu, T. Finlayson, and V. Guilin Self-Reported Tuberculosis Disease and Tuberculin Skin Testing in the New York City House Ballroom Community Am J Public Health, June 1, 2008; 98(6): 1068 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Albalak, R. J. O'Brien, J. S. Kammerer, S. M. O'Brien, S. M. Marks, K. G. Castro, and M. Moore Trends in Tuberculosis/Human Immunodeficiency Virus Comorbidity, United States, 1993-2004 Arch Intern Med, December 10, 2007; 167(22): 2443 - 2452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Macaraig, T. Agerton, C. R. Driver, S. S. Munsiff, J. Abdelwahab, J. Park, B. Kreiswirth, J. Driscoll, and B. Zhao Strain-Specific Differences in Two Large Mycobacterium tuberculosis Genotype Clusters in Isolates Collected from Homeless Patients in New York City from 2001 to 2004. J. Clin. Microbiol., August 1, 2006; 44(8): 2890 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1169 - 1227. [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Brewer and S. J. Heymann The Long Journey to Health Equity JAMA, July 14, 2004; 292(2): 269 - 271. [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Williams and C. Dye Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS Science, September 12, 2003; 301(5639): 1535 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Eidlitz-Markus, A. Zeharia, G. Baum, M. Mimouni, and J. Amir Use of the Urine Color Test to Monitor Compliance With Isoniazid Treatment of Latent Tuberculosis Infection Chest, March 1, 2003; 123(3): 736 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Danes, J. Gonzalez-Martin, T. Pumarola, A. Rano, N. Benito, A. Torres, A. Moreno, M. Rovira, and J. Puig de la Bellacasa Pulmonary Infiltrates in Immunosuppressed Patients: Analysis of a Diagnostic Protocol J. Clin. Microbiol., June 1, 2002; 40(6): 2134 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Welch, A. Morse, and A. Lalvani Improving tuberculin skin testing in hiv-infected individuals Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1452 - 1452. [Full Text]
|
|
|
|
|
|
M. C. White, J. P. Tulsky, J. Goldenson, C. J. Portillo, M. Kawamura, and E. Menendez Randomized Controlled Trial of Interventions to Improve Follow-up for Latent Tuberculosis Infection After Release From Jail Arch Intern Med, May 13, 2002; 162(9): 1044 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L J King and S P G Padley Imaging of the thorax in AIDS Imaging, February 1, 2002; 14(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Brewer, S. J. Heymann, S. M. Krumplitsch, M. E. Wilson, G. A. Colditz, and H. V. Fineberg Strategies to Decrease Tuberculosis in US Homeless Populations: A Computer Simulation Model JAMA, August 15, 2001; 286(7): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Brill, Q. Li, R. Larkin, D. H. Canaday, D. R. Kaplan, W. H. Boom, and R. F. Silver Human Natural Killer Cells Mediate Killing of Intracellular Mycobacterium tuberculosis H37Rv via Granule-Independent Mechanisms Infect. Immun., March 1, 2001; 69(3): 1755 - 1765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Briscoe, D. R. Roach, N. Meadows, D. Rathjen, and W. J. Britton A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice J. Leukoc. Biol., October 1, 2000; 68(4): 538 - 544. [Abstract] [Full Text]
|
|
|
|
|
|
O. KIRK, J. M. GATELL, A. MOCROFT, C. PEDERSEN, R. PROENCA, R. P. BRETTLE, S. E. BARTON, P. SUDRE, A. N. PHILLIPS, and J. D. LUNDGREN Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected Patients after the Introduction of Highly Active Antiretroviral Therapy Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 865 - 872. [Abstract] [Full Text]
|
|
|
|
|
|
A. R. MOSS, J. A. HAHN, J. P. TULSKY, C. L. DALEY, P. M. SMALL, and P. C. HOPEWELL Tuberculosis in the Homeless . A Prospective Study Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 460 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lauzardo and D. Ashkin Phthisiology at the Dawn of the New Century Chest, May 1, 2000; 117(5): 1455 - 1473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Slovis, J. D. Plitman, and D. W. Haas The Case Against Anergy Testing as a Routine Adjunct to Tuberculin Skin Testing JAMA, April 19, 2000; 283(15): 2003 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection . This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This Statement was endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999, and the sections of this Statement as it relates to infants and children were endorsed by the American Academy of Pediatrics (AAP), August 1999. Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): S221 - 247. [Full Text] [PDF]
|
|
|
|
 |
|
 L.-M. Ting, A. C. Kim, A. Cattamanchi, and J. D. Ernst Mycobacterium tuberculosis Inhibits IFN-{gamma} Transcriptional Responses Without Inhibiting Activation of STAT1 J. Immunol., October 1, 1999; 163(7): 3898 - 3906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. SNYDER, E. A. PAZ, J. C. MOHLE-BOETANI, R. FALLSTAD, R. L. BLACK, and D. P. CHIN Tuberculosis Prevention in Methadone Maintenance Clinics . Effectiveness and Cost-Effectiveness Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 178 - 185. [Abstract] [Full Text]
|
|
|
|
 |
|
 C MAYAUD and J CADRANEL Tuberculosis in AIDS: past or new problems? Thorax, July 1, 1999; 54(7): 567 - 571. [Full Text]
|
|
|
|
 |
|
 D. V. Havlir and P. F. Barnes Tuberculosis in Patients with Human Immunodeficiency Virus Infection N. Engl. J. Med., February 4, 1999; 340(5): 367 - 373. [Full Text] [PDF]
|
|
|
|
|
|
H. Sawert, E. Girardi, G. Antonucci, M. C. Raviglione, P. Viale, G. Ippolito, and for the Gruppo Italiano di Studio Tubercolosi e AI Preventive Therapy for Tuberculosis in HIV-Infected Persons: Analysis of Policy Options Based on Tuberculin Status and CD4+Cell Count Arch Intern Med, October 26, 1998; 158(19): 2112 - 2121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Aguado, F. Pulido, S. Moreno, G. J. Dore, M. G. Law, J. M. Kaldor, F. Gordin, and J. Matts Isoniazid Prophylaxis for High-Risk Patients with Anergy and HIV Infection N. Engl. J. Med., December 4, 1997; 337(23): 1696 - 1697. [Full Text]
|
|
|
|
 |
|
 T. Lincoln, V. Lynch, and T. J. Conklin Skin Anergy Testing and Tuberculosis Surveillance Journal of Correctional Health Care, October 1, 1997; 4(2): 139 - 153. [Abstract] [PDF]
|
|
Article
